Prosecution Insights
Last updated: November 04, 2026
Application No. 18/689,940

PREPARATION METHOD FOR PERFLUOROOLEFIN OLIGOMER AND APPLICATION THEREOF

Final Rejection §103
Filed
Mar 07, 2024
Priority
Sep 07, 2021 — CN 202111045203.9 +1 more
Examiner
BAKSHI, PANCHAM
Art Unit
1623
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Zhejiang Juhua Technology Center Co. Ltd.
OA Round
2 (Final)
77%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 77% — above average
77%
Career Allowance Rate
902 granted / 1176 resolved
+16.7% vs TC avg
Strong +30% interview lift
Without
With
+30.1%
Interview Lift
resolved cases with interview
Typical timeline
2y 3m
Avg Prosecution
76 currently pending
Career history
1252
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
30.5%
-9.5% vs TC avg
§102
20.0%
-20.0% vs TC avg
§112
30.3%
-9.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1176 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of the Application Claims 13, 15-17, 19-30 are pending and under current examination. Amendment necessitated new claim rejection as set forth below. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102 of this title, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 13, 15-17, 19-30 are rejected under 35 U.S.C. 103 as being unpatentable over Zhejiang (CN110577460A; as provided by the applicant on IDS dated 03/07/2024) and Tianjin (CN109574812A); as provided by the applicant on IDS dated 03/07/2024) in combination. Determining the scope and contents of the prior art Zhejiang discloses method of making perfluorolefin oligomer of claims 16 and 17 with carbon atoms>7 comprising oligomerization reaction of HFP or HFP with other fluoro-containing olefin raw material in presence of catalyst metal fluoride salt with example of KF and a cocatalyst with examples of crown ether, 18-crown ether 5, 18-crown ether 6, wherein ratio of catalyst to catalyst is 0.1-10:1, preferably 0.5-2:1 in a solvent with example of DMF, acetonitrile, etc., at temperature of 30-80C, such as 50, 70C for time period, such as 1.5h and HFP: metal fluoride as 20-2000:1, 100-1000:1, 1:0.012 (encompass ratio of raw material : metal catalyst of the instant claims, such as 20:1, i.e., 1:0.5 and also encompass that cocatalyst is not higher than 10% of the raw material) (entire article). Ascertaining the differences between the prior art and the claims at issue Zhejiang discloses method of making perfluorolefin oligomer of claims 16 and 17 with carbon atoms>7 comprising oligomerization reaction of HFP or HFP with other fluoro-containing olefin raw material in presence of metal fluoride salt with example of KF in a solvent with example of DMF, acetonitrile, etc., at temperature of 30-80C, such as 50, 70C for time period, such as 1.5h and HFP: metal fluoride as 1:0.012 (entire article), but fails to teach the process with TFE, TFE oligomers or HFP oligomers and give example with time for reaction as 2-12hrs; specific 18crown 6 or 18 crown 5 of the instant claims. Resolving the level of ordinary skill in the pertinent art With regards to the above difference of oligomerization reaction of HFP with TFE, TFE oligomers or HFP oligomers etc.- Zhejiang discloses method of making perfluorolefin oligomer of claims 16 and 17 with carbon atoms>7 comprising oligomerization reaction of HFP or HFP with other fluoro-containing olefin raw material in presence of catalyst metal fluoride salt with example of KF and a cocatalyst with examples of crown ether, 18-crown ether 5, 18-crown ether 6, wherein ratio of catalyst to catalyst is 0.1-10:1, preferably 0.5-2:1 in a solvent with example of DMF, acetonitrile, etc., at temperature of 30-80C, such as 50, 70C for time period, such as 1.5h and HFP: metal fluoride as 20-2000:1, 100-1000:1, 1:0.012 (encompass ratio of raw material : metal catalyst of the instant claims, such as 20:1, i.e., 1:0.5 and also encompass that cocatalyst is not higher than 10% of the raw material). Thus, based on the guidance provided by the cited prior art, it would have been prima facie obvious to a person of ordinary skill in the art with a reasonable expectation of success that HFP may undergo oligomerization with other fluoro-containing olefin raw material, such as TFE, TFE oligomers or HFP oligomers etc. Further, it would have been prima facie obvious to a person of ordinary skill in the art with a reasonable expectation of success that other fluoro-containing olefin raw material in reaction taught by the cited prior art may be substituted with another fluoro-containing olefin. Thus, the cited prior art meets limitation of the instant claims. This deficiency is further cured by Tianjin. In the same field of endeavor, Tianjin teaches a method of making perfluorolefin oligomer of claims 16 and 17 with carbon atoms>7 comprising oligomerization reaction of HFP and/or HFP dimer, trimer; TFE and HFP; HFP and TFE dimer (perfluorobutene) (0025, 0026, 0041-0046, 0058-0069) in presence of metal fluoride salt with example of KF and a cocatalyst ammonium salt or phase transfer catalyst, crown ether, with examples 4-aminobenzyl-15-crown-5 etc., (same ethers as in the instant claims 28 and 30) of in a solvent with example of DMF, acetonitrile, etc., at temperature of 30-50C, for time period, such as 10h (entire article). Thus, based on the guidance provided by Zhejiang and Tianjin, it would have been prima facie obvious to a person of ordinary skill in the art with a reasonable expectation of success that HFP may undergo oligomerization with other fluoro-containing olefin raw material, such as TFE, TFE oligomers or HFP oligomers etc. Further, it would have been prima facie obvious to a person of ordinary skill in the art with a reasonable expectation of success that other fluoro-containing olefin raw material in reaction taught by Zhejiang may be substituted with another fluoro-containing olefin, such as taught by Tianjin. Thus, the cited prior art meets limitation of the instant claims. With regards to the above difference of time of reaction- Thus, based on the guidance provided by Zhejiang and Tianjin, it would have been prima facie obvious to a person of ordinary skill in the art with a reasonable expectation of success that reaction time may vary from 1.5hr-10hr depending on starting material and desired yield of final product. Further, differences in concentration, temperature, and the like, will not support the patentability of subject matter encompassed by the prior art unless there is evidence indicating such concentration or temperature is critical. “[W]here the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation.” In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955). Moreover, it is noted that all of the recited reaction parameters are recognized as result-effective variables, i.e., a variable which achieves a recognized result, before the determination of the optimum or workable ranges of said variable might be characterized as routine experimentation. In re Antonie, 559 F.2d 618, 195 USPQ 6 (CCPA 1977). With regards to the above difference of specific 18crown 6 or 18 crown 5 of the instant claims- Zhejiang teaches using cocatalyst crown ether with examples of 18-crown ether 5, 18-crown ether 6, and Tianjin teaches using cocatalyst ammonium salt or phase transfer catalyst, crown ether, with examples 4-aminobenzyl-15-crown-5 etc. Thus, based on the guidance provided by Zhejiang and Tianjin, it would have been prima facie obvious to a person of ordinary skill in the art with a reasonable expectation of success that reaction time may be carried out with crown ether 18-crown ether 5, 18-crown ether 6 or crown ether taught by Tianjin 4-aminobenzyl-15-crown-5 etc. Thus, the cited prior art meets limitation of the instant claims. Based on the above established facts, it appears that the teachings of above cited prior art read applicants’ process. Therefore, all the claimed elements were known in the prior art and one skilled person in the art could have modified the elements as claimed by known methods with no change in their respective functions, and the modification would have yielded predictable results to one of ordinary skill in the art at the time of the invention. Considering objective evidence present in the application indicating obviousness or nonobviousness To establish a prima facie case of obviousness, three basic criteria must be met: (1) the prior art reference must teach or suggest all the claim limitations; (2) there must be some suggestion or motivation, either in the references themselves or in the knowledge generally available to one of ordinary skill in the art, to modify the reference or to combine reference teachings; and (3) there must be a reasonable expectation of success; and (MPEP § 2143). In this case, method of making perfluorolefin oligomer of claims 16 and 17 with carbon atoms>7 comprising oligomerization reaction of HFP or HFP with other fluoro-containing olefin raw material in presence of catalyst metal fluoride salt with example of KF and a cocatalyst with examples of crown ether, 18-crown ether 5, 18-crown ether 6, wherein ratio of catalyst to catalyst is 0.1-10:1, preferably 0.5-2:1 in a solvent with example of DMF, acetonitrile, etc., at temperature of 30-80C, such as 50, 70C for time period, such as 1.5h and HFP: metal fluoride as 20-2000:1, 100-1000:1, 1:0.012 (encompass ratio of raw material : metal catalyst of the instant claims, such as 20:1, i.e., 1:0.5 and also encompass that cocatalyst is not higher than 10% of the raw material). Tianjin teaches a method of making perfluorolefin oligomer of claims 16 and 17 with carbon atoms>7 comprising oligomerization reaction of HFP and/or HFP dimer, trimer; TFE and HFP; HFP and TFE dimer (perfluorobutene) (0025, 0026, 0041-0046, 0058-0069) in presence of metal fluoride salt with example of KF and a cocatalyst ammonium salt or phase transfer catalyst, crown ether, with examples 4-aminobenzyl-15-crown-5 etc., (same ethers as in the instant claims 28 and 30) of in a solvent with example of DMF, acetonitrile, etc., at temperature of 30-50C, for time period, such as 10h. In KSR International Vo. V. Teleflex Inc., 82 USPQ2d (U.S. 2007), the Supreme Court particularly emphasized “the need for caution in granting a patent based on a combination of elements found in the prior art,” (Id. At 1395) and discussed circumstances in which a patent might be determined to be obvious. Importantly, the Supreme Court reaffirmed principles based on its precedent that “[t]he combination of familiar elements according to known methods is likely to be obvious when it does no more than yield predictable results.” (Id. At 1395). See MPEP 2143 - Examples of Basic Requirements of a Prima Facie Case of Obviousness [R-9]. In this case at least prong (E) “Obvious to try” – choosing from a finite number of identified, predictable solutions, with a reasonable expectation of success would apply. The rationale to support a conclusion that the claim would have been obvious is that “a person of ordinary skill has good reason to pursue the known options within his or her technical grasp. If this leads to the anticipated success, it is likely that product [was] not of innovation but of ordinary skill and common sense. In that instance the fact that a combination was obvious to try might show that it was obvious under § 103.”KSR, 550 U.S. at ___, 82 USPQ2d at 1397. If any of these findings cannot be made, then this rationale cannot be used to support a conclusion that the claim would have been obvious to one of ordinary skill in the art. Further, there is a reasonable expectation of success that time period for reaction may be adjusted depending on the desired yield of the product and can be made by teachings of the above cited prior art. Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention by taking advantage of the teaching of the above cited reference and to make the instantly claimed process with a reasonable expectation of success. Modifying such parameters is prima facie obvious because an ordinary artisan would be motivated to develop an alternative process for economic reasons or convenient purposes from a known individual reaction steps, and to arrive at applicants’ process with a reasonable expectation of success, since it is within the scope to modify the process through a routine experimentation. Response to arguments Applicants’ remarks and amendments filed on September 24, 2026, have been fully considered but not found persuasive. Applicants’ argument is moot in view of new rejection as set forth above. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to PANCHAM BAKSHI whose telephone number is (571)270-3463. The examiner can normally be reached M-Thu 7-4.30 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Milligan Adam can be reached at 571-2707674. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PANCHAM BAKSHI/Primary Examiner, Art Unit 1623
Read full office action

Prosecution Timeline

Mar 07, 2024
Application Filed
Jul 21, 2026
Non-Final Rejection mailed — §103
Sep 24, 2026
Response Filed
Oct 28, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12780850
PROCESS FOR SYNTHESIS OF ORGANOSILICON COMPOUNDS FROM HALOSILANES
3y 9m to grant Granted Nov 03, 2026
Patent 12768846
GOLD NONOCLUSTERS, DOPAMINE BIOSENSORS INCLUDING THEM, AND METHODS FOR DIAGNOSING NEUROLOGICAL DISEASES USING THE SAME
3y 6m to grant Granted Oct 20, 2026
Patent 12767628
METHOD FOR PREPARING ACRYLIC ACID
3y 4m to grant Granted Oct 20, 2026
Patent 12751963
Small Molecule Inhibitors of Viral Replication
4y 11m to grant Granted Oct 06, 2026
Patent 12751908
PEPTIDE COMPOSITION AND METHOD FOR PRODUCING SAME
4y 0m to grant Granted Oct 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
77%
Grant Probability
99%
With Interview (+30.1%)
2y 3m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1176 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month